Skip to content

Vysis 06N38-010

by Abbott Molecular

Ref 06N38-010

Vysis 06N38-010 is an in vitro diagnostic device (EU IVDR Class C; FDA Class II; EMDN category tests for acquired genetic or chromosomal alterations) made by Abbott Molecular, registered in EUDAMED on 4 Nov 2026 (Basic UDI-DI 0884999CDN0638UY) and listed in FDA GUDID since 20 Nov 2014 (UDI-DI 00884999025738), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number0884999CDN0638UY Basic UDI-DI 00884999025738UDI-DIDate4 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00884999025738 UDI-DI Date20 Nov 2014ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ProbeChek ALK Positive Control Slides
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 0884999CDN0638UY registered 4 Nov 2026 Active
  • FDA GUDID UDI-DI 00884999025738 listed 20 Nov 2014 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00884999025738
  2. Registered EUDAMED 0884999CDN0638UY

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Vysis
Generic name
Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
Device name
Vysis ALK Break Apart FISH Probe Kit
Model / Ref / Catalog
06N38-010
Primary DI / UDI-DI
00884999025738
Basic UDI-DI
0884999CDN0638UY
FDA product code
OYU, OWE
EMDN code
W01060299 Tests for acquired genetic or chromosomal alterations - other
GMDN term
Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
Device class
Class C EUDAMED
Class II GUDID
Regulation number
866.4700, 864.1890
EU registration type
Standard device
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class C
GUDID
Class II

Device class is stated on each registry's own scale: Class C in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER.

Other devices from Abbott Molecular

See all devices from Abbott Molecular →

Properties

  • Single use
  • Contains human tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Companion diagnostics
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (15, all answered No)